klausrose Consulting supports pharmaceutical companies in preparing, submitting, negotiating and executing pediatric investigation plans (PIPs) with the European Medicines Agency (EMA) and the EU Paediatric Committee (PDCO), and supporting companies in the preparing a pediatric plan (PP) in dialogue with the FDA. Dr. Klaus Rose, founder and CEO, qualified 1986 in medicine in Berlin after having studied Romanic languages and psychology. He completed his postgraduate clinical training in General Medicine in Germany and England and joined pharmaceutical industry in 1991. He has held various positions in R&D and medical affairs of progressive responsibility in different companies culminating in the position of Global Head Pediatrics at Novartis in 2002 - 2005 and then the same position at Roche 2005 - 2009. From 2010 until March 2011 he was Principal Consultant with Granzer Regulatory Affairs in Munich, Germany. Dr. Rose is a frequent speaker on international conferences on pediatric drug development and publishes on this theme on a regular base. The second edition of “Guide to Paediatric Drug Development and Clinical Research“, which he edited together with Professor John van den Anker, was released May 2010. Married with two daughters, his private interests include Mediterranean cooking, wine, gardening, Romanic languages, and classical guitar.